Literature DB >> 7212646

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.

P J Dyck, W R Sherman, L M Hallcher, F J Service, P C O'Brien, L A Grina, P J Palumbo, C J Swanson.   

Abstract

Fascicles of the sural nerve from each of 20 diabetic patients, mostly with maturity-onset diabetes, were studied by biochemical and pathological techniques, and results were compared to values found in nerve specimens from 15 healthy persons. The sorbitol and fructose content was much more variable in diabetic than in healthy nerves. More than one-third of the diabetic nerves had sorbitol and fructose values above the highest levels for controls. myo-Inositol and scyllo-inositol content was not reduced in diabetic nerves. The sorbitol, fructose, and inositol concentrations could not be related to clinical, neurophysiological, or pathological severity of neuropathy. A comparison of scored symptoms and signs and clinical neurophysiological studies against morphometric and teased fiber studies of sural nerve demonstrated that the former three provide sensitive and reliable measures of severity of neuropathy that can be used for controlled clinical trials of diabetic neuropathy. The presence and type of teased fiber abnormalities could be related to the duration of diabetes and to symptoms of neuropathy. In untreated diabetics without symptoms of neuropathy, a higher than normal frequency of teased fibers showing segmental demyelination and remyelination was found. Untreated diabetics with symptomatic neuropathy showed two kinds of abnormalities: fibers with segmental demyelination and remyelination and fibers undergoing axonal degeneration. In treated diabetics, who often had longstanding neuropathy, the most common abnormalities were fibers undergoing axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7212646     DOI: 10.1002/ana.410080608

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  109 in total

1.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

Authors:  X Mariette; C Chastang; P Clavelou; J P Louboutin; J M Leger; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Motor pathway function in normoalbuminuric IDDM patients.

Authors:  H Andersen; J F Nielsen; P L Poulsen; C E Mogensen; J Jakobsen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

3.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Endoneurial capillary abnormalities in mild human diabetic neuropathy.

Authors:  R A Malik; A Veves; E A Masson; A K Sharma; A K Ah-See; W Schady; R H Lye; A J Boulton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

5.  Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P H Hendriksen; P L Oey; G H Wieneke; B Bravenboer; J D Banga
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

6.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

7.  Simplified diagnostic criteria for diabetic distal polyneuropathy. Preliminary data of a multicentre study in the Campania region. S.I.M.S.D.N. Group.

Authors:  S Gentile; S Turco; G Corigliano; R Marmo
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

8.  Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.

Authors:  Sindhu Ramchandren; Marcia Leonard; Rajen J Mody; Janet E Donohue; Judith Moyer; Raymond Hutchinson; James G Gurney
Journal:  J Peripher Nerv Syst       Date:  2009-09       Impact factor: 3.494

Review 9.  Diabetic neuropathies. Current concepts in prevention and treatment.

Authors:  J D Ward
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

10.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.